Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Epping
Clinical trial register · Australia

Clinical Trials in Epping, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3348 matching records held by the registry are in this view. Synced 18 Oct 2026, 03:18 UTC
3348
Studies in scope
all four open statuses
1802
Recruiting now
open to new participants
765
Lead sponsors
across recruiting studies
Top sites
Melbourne 1099 Adelaide 566 Sydney 511 Westmead 417 Clayton 408
Narrow the registerReset
Recruitment status
Phase
Site location
Melbourne1099 Adelaide566 Sydney511 Westmead417 Clayton408
All 399 locations
Target enrolment
to

Trials with a site in Epping

25 of 3348 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Recruiting
Genfleet Therapeutics (Shanghai) Inc.
Phase 1/2
222
Concord, North Ryde, Woodville South, Clayton, Epping, Frankston
2026-09
Recruiting
Prevention of Reperfusion Injury Outcomes Through Effective Cardioprotection Targeting Myocardial Infarction
NCT07362446Myocardial Infarction, Reperfusion Injury, AMI, STEMI (ST Elevation MI)
Nyrada Pty Ltd
Phase 2
300
Kingswood, Liverpool, Adelaide, Epping, Frankston, Saint Albans, Nedlands, Perth
2026-07-02
Recruiting
Bristol-Myers Squibb
Phase 3
850
Gosford, Penrith, Westmead, Elizabeth Vale, Ballarat Central, Epping, Joondalup
2026-03-16
Recruiting
Bristol-Myers Squibb
Phase 3
750
Gosford, Penrith, Elizabeth Vale, Ballarat Central, Epping, Joondalup
2026-03-12
Recruiting
Bayer
Phase 1/2
450
Camperdown, Concord, Epping, Waratah
2025-03-21
Recruiting
Hoffmann-La Roche
Phase 3
600
Garran, Sydney, Herston, South Brisbane, Woolloongabba, Adelaide, Epping, Murdoch
2025-03-17
Recruiting
Ascentage Pharma Group Inc.
Phase 3
490
Blacktown, Cooloongup, Epping, Heidelberg, Kingswood, Liverpool, Melbourne, Perth
2025-01-22
Recruiting
Institut de Recherches Internationales Servier
Phase 3
48
Adelaide, Clayton, Epping, Liverpool, Nedlands, Waratah
2024-12-03
Recruiting
VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease
NCT06257706Moderately to Severely Active Crohn's Disease, Crohn Disease, Disease Crohn
Alimentiv Inc.
Phase 4
304
Concord, South Brisbane, Adelaide, Woodville, Epping, Heidelberg, Melbourne, Murdoch
2024-08-07
Active, closed
Syndax Pharmaceuticals
Phase 1
96
Epping, Perth, Adelaide, Melbourne, Nedlands
2024-05-21
Active, closed
Novo Nordisk A/S
Phase 3
673
Garran, New Lambton Heights, Wollongong, Brisbane, Chermside, Ballarat, Epping, Mulgrave
2024-04-01
Active, closed
Gilead Sciences
Phase 2
228
Sydney, South Brisbane, Woolloongabba, Woodville, Clayton, Epping, Fitzroy, Footscray
2024-03-27
Recruiting
Takeda
Phase 2
268
Concord, South Brisbane, Bedford Park, Woodville, Footscray, Murdoch, Perth, Epping
2024-03-05
Active, closed
Gilead Sciences
Phase 2
176
Birtinya, South Brisbane, Woolloongabba, Adelaide, Woodville, Epping, Murdoch
2023-12-05
Recruiting
Gilead Sciences
Phase 3
402
Queensland, Adelaide, Clayton, Epping, Melbourne
2023-09-07
Active, closed
Bayer
Phase 3
985
Camperdown, Epping, Liverpool, Wahroonga, Adelaide, Box Hill, East Melbourne, Geelong
2023-04-03
Recruiting
Eupraxia Pharmaceuticals Inc.
Phase 1/2
117
Sydney, Brisbane, Maroochydore, Adelaide, Box Hill, Epping, Melbourne, Parkville
2023-03-31
Recruiting
Smith & Nephew, Inc.
Not applicable
140
Epping
2022-02-12
Active, closed
Australasian Gastro-Intestinal Trials Group
Not applicable
6
Albury, Bendigo, Box Hill, Epping, Fitzroy, Geelong, Melbourne, Saint Albans
2021-12-14
Active, closed
Merck Sharp & Dohme LLC
Phase 2
730
Gosford, Westmead, Epping, Malvern
2021-08-18
By invitation
Viatris Innovation GmbH
Phase 3
25,000
Adelaide, Ballarat, Chermside, Clayton, Concord, Epping, Garran, Gosford
2021-08-14
Active, closed
Mirum Pharmaceuticals, Inc.
Phase 2
182
Adelaide, Epping, Liverpool, Melbourne, Sippy Downs
2020-12-18
Rows per page Showing 1–25 of 25
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 18 October 2026. https://priyalifescience.com/clinical-trials-australia/city/epping

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,348 studies in total at the last sync on 18 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 25 of those studies with a site in Epping.

How many clinical trials are recruiting in Epping?

15 of the 25 studies on this page are recruiting new participants as of the 18 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 9 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Epping), 25 studies
PhaseStudiesRecruitingShare
Phase 311744%
Phase 27328%
Phase 1/23312%
Not applicable218%
Phase 1104%
Phase 4114%

Most active sponsors

Lead sponsors with the most studies (Epping)
Lead sponsorStudiesRecruiting
Gilead Sciences31
Bayer21
Bristol-Myers Squibb22
Merck Sharp & Dohme LLC21
AbbVie11
Akero Therapeutics, Inc10
Alimentiv Inc.11
Ascentage Pharma Group Inc.11
Australasian Gastro-Intestinal Trials Group10
Eupraxia Pharmaceuticals Inc.11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.